Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Menopause. 2018 Jul;25(7):811–816. doi: 10.1097/GME.0000000000001075

Table 3.

Adjusted associations between 25(OH)D and ovarian reserve biomarkers.a

AMH, b Percent Difference (CI) FSH, b Percent Difference (CI) Inhibin-B c, Beta pg/ml (CI)

N=561 N=502 N=502
25(OH)D, per 10ng/ml decrease −3.3 (−12, 4.8) 0.53 (−3.8, 4.7) −1.0 (−3.0, 5.1)
Annual mean 25(OH)D, per 10ng/ml decrease −3.0 (−12, 5.1) 0.54 (−3.8, 4.7) −1.2 (−2.8, 5.2)
Insufficient 25(OH)Dd −17 (−31, 0.2) 8.7 (−0.86, 19) 3.2 (−5.5, 12)
a

Adjusted for age, race, smoking history, BMI and recent use of hormonal birth control

b

Natural log-transformed.

c

Inhibin-B is not log-transformed.

d

25(OH)D less than 30 ng/ml, the Endocrine Society guideline for sufficiency, compared with at least 30 ng/ml